Toward Biomarker-Guided Treatment in Psychosis

By Brian Miller, MD, PhD, MPH

Is oxidative stress a therapeutic target in schizophrenia?

slideshow image

Is oxidative stress a therapeutic target in schizophrenia?

Related Videos
View All
Related Content

Recovery-Oriented Cognitive Therapy: Changing Lives With a Whole-Person Approach

January 23rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

FDA-Approved: Risperidone Extended-Release Injectable Suspension

January 17th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Rare Copy Number Variants in Treatment-Resistant Psychosis

January 12th 2023

The Book of Opportunities

January 9th 2023

Recovery-Oriented Cognitive Therapy: Changing Lives With a Whole-Person Approach

January 23rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

FDA-Approved: Risperidone Extended-Release Injectable Suspension

January 17th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Rare Copy Number Variants in Treatment-Resistant Psychosis

January 12th 2023

The Book of Opportunities

January 9th 2023

Recovery-Oriented Cognitive Therapy: Changing Lives With a Whole-Person Approach

January 23rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

FDA-Approved: Risperidone Extended-Release Injectable Suspension

January 17th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Rare Copy Number Variants in Treatment-Resistant Psychosis

January 12th 2023

The Book of Opportunities

January 9th 2023
Advertise
Contact Us
Editorial
Terms and Conditions
Privacy Policy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.